Falter T, Hennige AM, Schulz A, et al. Prevalence of Overweight and Obesity, Its Complications, and Progression in a 10-Year Follow-Up in the Gutenberg Health Study (GHS). Obes Facts. 2024;17(1):12–23. https://doi.org/10.1159/000533671.
Article CAS PubMed Google Scholar
Kurnool S, McCowen KC, Bernstein NA, et al. Sleep Apnea, Obesity, and Diabetes - an Intertwined Trio. Curr Diab Rep. 2023;23(7):165–71. https://doi.org/10.1007/s11892-023-01510-6.
Article CAS PubMed PubMed Central Google Scholar
Csige I, Ujvárosy D, Szabó Z, et al. The Impact of Obesity on the Cardiovascular System. J Diabetes Res. 2018;2018:3407306. https://doi.org/10.1155/2018/3407306.
Article CAS PubMed PubMed Central Google Scholar
Aminian A, Zajichek A, Arterburn DE, et al. Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity. JAMA. 2019;322(13):1271–82. https://doi.org/10.1001/jama.2019.14231.
Article PubMed PubMed Central Google Scholar
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017;376(7):641–51. https://doi.org/10.1056/NEJMoa1600869.
Article PubMed PubMed Central Google Scholar
Bezerra A, Boppre G, Freitas L, et al. Body Composition Changes in Adolescents Who Underwent Bariatric Surgery: A Systematic Review and Meta-analysis. Curr Obes Rep. 2024;13(1):107–20. https://doi.org/10.1007/s13679-023-00549-6.
Article PubMed PubMed Central Google Scholar
Nuijten MAH, Monpellier VM, Hopman MTE, et al. Rate and Determinants of Excessive Fat-Free Mass Loss After Bariatric Surgery. Obes Surg. 2020;30(8):3119–26. https://doi.org/10.1007/s11695-020-04654-6.
Article PubMed PubMed Central Google Scholar
Nuijten MAH, Eijsvogels TMH, Montpellier VM, et al. The magnitude and progress of lean body mass, fat-free mass, and skeletal muscle mass loss following bariatric surgery: A systematic review and meta-analysis. Obes Rev. 2022;23(1). https://doi.org/10.1111/obr.13370.
AziziKia H, Shojaei S, Mousavi A, et al. Periprocedural Changes of Serum Biomarkers in Predicting Complications Following Bariatric Surgery for Obesity: Systematic Review and Meta-analysis. Obes Surg. 2024;34(6):2198–215. https://doi.org/10.1007/s11695-024-07234-0.
Liu XY, Zhang X, Zhang Q, et al. The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer. Support Care Cancer. 2023;31(9):533. https://doi.org/10.1007/s00520-023-07997-9.
Nakashima K, Haruki K, Kamada T, et al. Usefulness of the C-Reactive Protein (CRP)-Albumin-Lymphocyte (CALLY) Index as a Prognostic Indicator for Patients With Gastric Cancer. Am Surg. 2024;31348241248693. https://doi.org/10.1177/00031348241248693
Yang M, Lin SQ, Liu XY, et al. Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study. Front Immunol. 2023;14:1131496. https://doi.org/10.3389/fimmu.2023.1131496.
Article CAS PubMed PubMed Central Google Scholar
Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127(1):1–4. https://doi.org/10.1172/jci92035.
Article PubMed PubMed Central Google Scholar
Cohen E, Margalit I, Shochat T, et al. Markers of Chronic Inflammation in Overweight and Obese Individuals and the Role of Gender: A Cross-Sectional Study of a Large Cohort. J Inflamm Res. 2021;14:567–73. https://doi.org/10.2147/jar.S294368.
Article PubMed PubMed Central Google Scholar
Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: Pathogenesis and Clinical Significance. JPEN J Parenter Enteral Nutr. 2019;43(2):181–93. https://doi.org/10.1002/jpen.1451.
Article CAS PubMed Google Scholar
Stępień A, Stępień M, Wlazeł RN, et al. Assessment of the relationship between lipid parameters and obesity indices in non-diabetic obese patients: a preliminary report. Med Sci Monit. 2014;20:2683–8. https://doi.org/10.12659/msm.890845.
Article PubMed PubMed Central Google Scholar
Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022;18(12):1345–56. https://doi.org/10.1016/j.soard.2022.08.013.
Mathew G, Agha R, Albrecht J, et al. STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg. 2021;96: 106165. https://doi.org/10.1016/j.ijsu.2021.106165.
Ignacio de Ulíbarri J, González-Madroño A, de Villar NG, et al. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp. 2005;20(1):38–45.
Bulló M, García-Lorda P, Megias I. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res. 2003;11(4):525–31. https://doi.org/10.1038/oby.2003.74.
Khanna D, Khanna S, Khanna P, et al. Obesity: A Chronic Low-Grade Inflammation and Its Markers. Cureus. 2022;14(2): e22711. https://doi.org/10.7759/cureus.22711.
Article PubMed PubMed Central Google Scholar
Shadnoush M, RajabianTabesh M, Asadzadeh-Aghdaei H, et al. Effect of bariatric surgery on atherogenicity and insulin resistance in patients with obesity class II: a prospective study. BMJ Open. 2023;13(6): e072418. https://doi.org/10.1136/bmjopen-2023-072418.
Article PubMed PubMed Central Google Scholar
Chi PJ, Wu KT, Chen PJ, et al. The serial changes of Neutrophile-Lymphocyte Ratio and correlation to weight loss after Laparoscopic Sleeve Gastrectomy. Front Surg. 2022;9: 939857. https://doi.org/10.3389/fsurg.2022.939857.
Article PubMed PubMed Central Google Scholar
Vaurs C, Diméglio C, Charras L, et al. Determinants of changes in muscle mass after bariatric surgery. Diabetes Metab. 2015;41(5):416–21. https://doi.org/10.1016/j.diabet.2015.04.003.
Article CAS PubMed Google Scholar
Holanda N, Crispim N, Carlos I, et al. Musculoskeletal effects of obesity and bariatric surgery - a narrative review. Arch Endocrinol Metab. 2022;66(5):621–32. https://doi.org/10.20945/2359-3997000000551.
Article PubMed PubMed Central Google Scholar
Liu J, Hu X. Association between glucose-to-lymphocyte ratio and in-hospital mortality in acute myocardial infarction patients. PLoS ONE. 2023;18(12): e0295602. https://doi.org/10.1371/journal.pone.0295602.
Article CAS PubMed PubMed Central Google Scholar
Yılmaz A, Şimşek M, Hannarici Z, et al. The importance of the glucose-to-lymphocyte ratio in patients with hepatocellular carcinoma treated with sorafenib. Future Oncol. 2021;17(33):4545–59. https://doi.org/10.2217/fon-2021-0457.
Article CAS PubMed Google Scholar
Zhang Y, Xu Y, Wang D, et al. Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer. Int J Clin Oncol. 2021;26(1):135–44. https://doi.org/10.1007/s10147-020-01782-y.
Article CAS PubMed Google Scholar
Güler İ, Ustaalioğlu İ. Predictive power of HALP score in estimating short-term mortality in patients with acute pancreatitis. Ulus Travma Acil Cerrahi Derg. 2023;29(10):1098–102. https://doi.org/10.14744/tjtes.2023.84970.
留言 (0)